Projekt

BASE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study

Abgeschlossen - Rekrutierung – beendet · 2013 bis 2023

Rubbert-Roth Andrea, Bartz-Batliner Mira